让我们以分子肿瘤学为例。
另外，在非肿瘤治疗领域，随着从分子生物学角度更好的理解疾病，对于特定靶点药物的研究有所增加。
Also, in nononcologic therapeutic areas understanding the molecular biology of the disease increases; thus, the chances of developing specific targeted drugs increase.
肿瘤是一种基因疾病，在当前分子生物学领域中，细胞癌变与细胞信号传导系统、细胞周期调控、细胞的生长和分化，以及细胞凋亡等均有关联。
Tumor is a kind of gene disease in the field of molecular biology, canceration is correlated with signal transduction system, regulate of cell cycle, differentiation and development of cell apoptosis.
EN的建立，为深入研究内、外分泌胰腺肿瘤的各种细胞和分子生物学特性提供了一个较有价值的体外模型。
The establishment of PC en cell line will provide a useful model in vitro for further investigating the cellular and molecular biology of exocrine and endocrine tumors of the pancreas.
OPN可能是肿瘤形成过程中的早期分子事件，可作为监测肿瘤恶性进展的一个生物学标志。
OPN expression may be an early molecular event in the process of tumorigenesis and could be used as a biological marker to monitor the malignant process of osteosarcoma.
目的探讨共刺激分子B7 1 (CD80)在血液系统恶性肿瘤发病学及免疫基因治疗中的重要作用。
Objective to explore the significance of costimulatory molecule B7-1 (CD80) and MHC molecules in the pathogenesis of hematologic malignant tumors and in the immuno-genetic therapy.
目的通过检测肿瘤抑制基因产物pten蛋白在肝癌中的表达情况，探讨其作为一种评估肝细胞癌(HCC)生物学特征的分子标记的意义。
Objective to detect the expression of PTEN protein in hepatocellular carcinoma (HCC) to determine whether it can be used as a new molecular label for evaluation of biological characteristics of HCC.
随着分子生物学及基因工程技术的出现及应用，肿瘤疫苗的研究已成为主动性免疫治疗的重要手段之一。
The research on tumor vaccine has been a key method of tumor active immunotherapy with the development and application of molecular biological and genetic engineering technology.
DNA甲基化与肿瘤临床关系是目前肿瘤分子生物学研究的热点。
Clinical relationship between DNA Methlation and tumor is the study hot in oncomolecularbiology at present.
目的：在基因组水平上探讨乌三颗粒抗肿瘤的分子生物学机制。
Objective: To investigate the molecular biological mechanism, on genomic level, of using Wusan Granule in treating Lewis lung carcinoma.
学习课程包括遗传学，免疫学，临床肿瘤学，分子疗法及相关学科。
Courses of study include genetics, immunology, clinical oncology, molecular therapeutics, and related subjects.
探讨肝癌肝动脉栓塞化疗后肿瘤的病理及某些分子生物学的变化。
Objective: To observe the pathological and molecular changes of the primary liver carcinoma after chemoembolization.
肿瘤细胞生物学及分子生物学的研究进展，为中药抗肿瘤研究提供了新的思路及方法。
The development of tumor cytobiology and molecular biology provide new methods for Chinese herbal medicine against tumor.
分子生物学诊断方法可以用于术前甲状腺良恶性肿瘤的辅助鉴别诊断，提供一个更为合理的治疗方案。
This review article primarily discusses biological markers used to aid the differential diagnosis of thyroid neoplasia, which may lead to a more rational approach to the treatment.
为今后临床应用分子生物学手段或基因治疗肿瘤提供资料。
Our research may be helpful to gene treatment of glioma by molecular biology methods.
目的射频消融治疗肝脏肿瘤的机制目前尚不明了，我们通过本实验观察射频治疗后兔肿瘤模型及临床肝癌病例的分子生物学改变。
Objective To study the molecular biological alterations in rabbit hepatic cancer models and clinical hepatic cancer cases subject to radio-frequency ablation (RFA).
从细胞生物学及分子生物学水平，立足于中药对机体免疫功能、对血管血液系统、对癌前病变的影响及有关方面探讨了中药抗恶性肿瘤的有关机理。
This paper deals with the mechanisms of the treatment with reference to cytobiology and molecular biology and the effect of Chinese medicine on immunity, the blood system and pathological changes.
肿瘤细胞线粒体及线粒体DNA的研究已从形态学改变进展至分子水平的变化。
The research on mitochondrion and mitochondrial DNA in tumor cells has developed from morphological changes to molecular alterations.
分子诊断是分子病理研究的最主要内容和手段，对肿瘤病理学研究由形态学深入到分子水平具有十分重要的意义。
Molecular diagnosis has important significance for development of tumor pathology from morphological to molecular level as it is the main contents and methods of molecular pathology.
用分子细胞生物学、生物化学、遗传学等手段研究肿瘤细胞内的信号传导通路与肿瘤发生机理；筛选肿瘤治疗特异性靶标与新药开发。
Using molecular cell biology, biochemistry, genetics and other approaches to study the signal transduction pathways in cancers and establish tumor targeting strategy for drug development.
综述了肿瘤分子流行病学和肿瘤易感基因生物学标志的研究现状，并展望了肿瘤分子流行病学研究的机遇和挑战。
We reviewed the advances of molecular cancer eipdemiology and biomarkers of cancer susceptibility gene. The chances and challenge of molecular cancer eipdemiology research were also discussed.
肿瘤预防的分子生物学基础- - -我们能战胜肿瘤吗？
Can We Win the Battle against Cancer? The Molecular Basis of Cancer Prevention.
当前科研研究方向为肿瘤环境流行病学、分子流行病学研究。
Currently mainly focus on environmental epidemiology of tumor and molecular epidemiology.
在哈佛医学院完成分子生物学的研究后，朱医生在纽约纪念斯隆-凯特琳癌症中心完成了肿瘤专科培训。
After a fellowship in molecular biology at Harvard Medical School, he was a Mortimer Lacher Fellow in medical oncology at Memorial Sloan-Kettering Cancer Center in New York City.
职位职责：1．硕士学历，分子生物学、细胞生物学、基础医学、药理学等相关专业；肿瘤领域研究背景；
Minimum requirements: The candidate is expected has master in Biochemistry, Molecular Biology, Cell Biology, Pharmacology or related field and have cancer relevant research experience.
职位职责：1．硕士学历，分子生物学、细胞生物学、基础医学、药理学等相关专业；肿瘤领域研究背景；
Minimum requirements: The candidate is expected has master in Biochemistry, Molecular Biology, Cell Biology, Pharmacology or related field and have cancer relevant research experience.
应用推荐